I try not to editorialize too much in this space, but today I’m going on a small screed. I simply want to ask… What the hell is the Fed doing? No need to bury the lede; Chairman Powell should raise rates a full 1% (100 basis points) next...
Read More
Market Recap For September 15th, 2022 Thursday wasn’t as informative as traders might have liked but breaching Wednesday’s lows would not be perceived as bullish. The S&P managed to hold the 3900 mark, but a trendline break and inability...
Read More
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm’s products include Chenodal, Cholbam, and...
Read More
August CPI numbers are in, and it’s not pretty. At all… Analysts expected to see a drop in prices from August’s CPI report, due in part to gas prices falling, but instead of the 8.1% the market had been expecting, 8.3% was the actual figure....
Read More